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Background: In western societies, atrial fibrillation is an increasingly common finding among the elderly.
Established risk factors of atrial fibrillation include obesity, diabetes, hypertension, and cardiovascular disease. Atrial
fibrillation has almost exclusively been studied in western populations where these risk factors are widely present.
Therefore, we studied the epidemiology of atrial fibrillation in a traditional African community.
Methods: In rural Ghana, among 924 individuals aged 50 years and older, we recorded electrocardiograms to
detect atrial fibrillation. As established risk factors, we documented waist circumference, body mass index (BMI),
capillary glucose level, blood pressure, and electrocardiographic myocardial infarction. In addition, we determined
circulating levels of interleukin-6 (IL6), a proinflammatory cytokine, and C-reactive protein (CRP), a marker of systemic
inflammation. We compared the risk factors with reference data from the USA.
Results: Atrial fibrillation was detected in only three cases, equalling 0.3% (95% CI 0.1–1.0%). Waist circumference,
BMI, and capillary glucose levels were very low. Hypertension and myocardial infarction were uncommon.
Circulating levels of IL6 were similar, but those of CRP were lower compared with the USA.
Conclusion: Atrial fibrillation is very scarce in this traditional African community. Its low prevalence compared with
western societies can be explained by the rareness of its established risk factors, which are closely related to
lifestyle, and by possible unmeasured differences in other risk factors or genetic factors.
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Atrial fibrillation is a common finding among elderly in
western societies. Its prevalence increases over age and
mounts to 10 to 20% after the age of 80 years [1,2]. Due
to ageing of western populations and improved survival
from other cardiovascular disorders, the prevalence of
atrial fibrillation has grown over time and is expected to
continue growing. As it leads to a heightened risk of
thromboembolism, cerebrovascular accidents, and con-
gestive heart failure, its public health burden has grown
concurrently [3,4].
The majority of the cases of atrial fibrillation can be
attributed to the established risk factors obesity, dia-
betes, hypertension, prior cardiac disease, and smoking.
Hypertension is the most important of these, responsible
for at least one fifth of the cases [5,6]. Still, questions* Correspondence: j.j.e.koopman@lumc.nl
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reproduction in any medium, provided the orremain about the pathogenesis of atrial fibrillation. It is
postulated that, next to these risk factors, inflammation
plays an important role in the pathogenesis of atrial fib-
rillation, but this has not yet been confirmed [1,7].
Moreover, it is not clearly understood why atrial fibrilla-
tion is less commonly detected in black Americans,
while they are more often affected by obesity, diabetes,
and hypertension than white Americans [5,8,9]. How-
ever, the epidemiology of atrial fibrillation has been stud-
ied almost exclusively in western societies [1,3], where
obesity, diabetes, hypertension, cardiovascular disease,
and systemic inflammation are widely present among
the elderly [10]. Little is known about the prevalence of
atrial fibrillation in non-western societies, such as in
rural Africa [11,12]. Knowledge about the risk of atrial
fibrillation in the context of different environmental and
genetic influences may provide more insight in its patho-
genesis [13].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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lation in a traditional rural African community where a
sedentary lifestyle is absent. We used electrocardiog-
raphy to detect atrial fibrillation among inhabitants aged
50 years and older. Established risk factors of atrial
fibrillation have been documented, such as obesity, dys-
glycaemia, hypertension, and myocardial infarction. Cir-
culating levels of interleukin-6 were measured as a
marker of proinflammatory immune activation and cir-
culating levels of C-reactive protein as a marker of sys-
temic inflammation.
Methods
Research area
The Upper East Region is remote, rural, and one of the
least developed regions of Ghana. The vast majority of
the inhabitants is involved in non-commercial agricul-
ture performed by manual labour [14]. The yearly per
capita income averages US$ 135 [15]; 88% of the house-
holds lives in poverty [16]. Infectious diseases are the
main causes of death [17].
Since 2002, we have registered and followed a trad-
itional horticultural community in the Garu-Tempane
District in the Upper East Region. This community oc-
cupies a research area of 375 km2 with approximately
25,000 inhabitants living in 32 villages. Migration is less
than 1% per year [14,18,19]. Hospital care is absent; the
nearest physician is at 40 kilometers’ distance. Sewage
disposal systems are non-existent.
All inhabitants have been registered in a demographic
database, including the name, age, sex, tribe, and house-
hold. We have determined the lifetime fertility, defined
as the total number of children born per postreproduc-
tive woman, based on fertility data gathered in the re-
search area in 2003 [19]. For each household, we have
determined the household property value in 2007 ac-
cording to the Demographic and Health Survey method
[14]. In 2008, we have determined the prevalences of
infections by malaria species by PCR of blood samples
and those by helminths and protozoa by PCR of stool
samples [20]. A more elaborate description of this co-
hort has been given elsewhere [14,18,19].
Study population
Within the registered community, we aimed to esti-
mate the prevalences of atrial fibrillation and its risk
factors among individuals aged 50 years and older. For
this, we set up a mobile field station in different vil-
lages during two field visits in 2009 and 2010. From
here, all eligible inhabitants were approached. Inclu-
sion was limited by the duration of the field visits. To
ensure maximal participation and to avoid selective in-
clusion of healthy elderly, we brought less mobile par-
ticipants by car. Of the approached inhabitants, 4.4%could not participate due to death since the last regis-
tration, 3.2% refused participation, 2.8% was absent
from the research area during our visit because of
migration or travelling, and 4.2% did not participate
for other reasons. At the field work station, the identity
of the participant was confirmed, the personal data
in our registration were checked, and clinical and
electrocardiographic investigations were performed. In
addition, blood plasma samples were available of 266
individuals randomly selected across age groups in
2008. On these samples biochemical investigations were
performed.
Ethical approval
Ethical approval was given by the Ethical Review
Committee of Ghana Health Service, the Committee
Medical Ethics of the Leiden University Medical Center,
and by the local chiefs and elders. Because of illiteracy, in-
formed consent was obtained orally from the participants.
A consent form with an explanation on the purpose and
conduction of this research project was read out to each
participant in his own language. The full text of the form
was approved by the Ethical Review Committee of Ghana
Health Service.
Electrocardiographic investigations
A twelve-lead electrocardiogram was recorded twice for
ten seconds in a lying and resting position (Schiller AT-
104 PC). All electrocardiograms were assessed by an
experienced cardiologist according to the Minnesota cri-
teria. The cardiologist was blinded for the participants’
characteristics other than age and sex. A subset of the
electrocardiograms (n = 610) was assessed for myocardial
infarction [21]. The heart rate was described using both
recordings. Bradycardia was defined as a sinus rhythm
below 60/min on either recording. Tachycardia was de-
fined as a sinus rhythm over 100/min on either record-
ing. The electrocardiograms were classified as whether
or not displaying atrial fibrillation or atrial flutter (codes
8-3-1, 8-3-2, 8-3-3, and 8-3-4).
Clinical and biochemical investigations
We performed clinical investigations on those participating
in the electrocardiographic investigations. We measured
height, weight, waist circumference, glucose capillary
blood concentration, and blood pressure. Body mass index
(BMI) was calculated as weight divided by squared height
(kg/m2). Hypertension was defined as a systolic blood
pressure of 140 mmHg or higher and/or a diastolic blood
pressure of 90 mmHg or higher [22].
We performed biochemical investigations on venous
blood samples, collected in randomly selected individuals
in 2008 (n = 266) [23] to measure circulating plasma levels
of interleukin-6 (IL6) and C-reactive protein (CRP).
Table 1 General characteristics of the Ghanaian study
population (age ≥ 50 years)
Individuals n 924
Age median (iqr) years 66 (56–73)
Age groups n (%)
50–59 years 307 (33.2)
60–69 years 291 (31.5)
70–79 years 242 (26.2)
80+ years 84 (9.1)
Male sex n (%) 480 (51.9)
Lifetime fertility median (iqr) children per woman 7 (6–9)
Households n 636
Household property value median (iqr) US$ 1,077 (533–1,942)
Waist circumference median (iqr) cm 76 (72–81)
Body mass index median (iqr) kg/m2 18.1 (16.5–19.5)
Capillary glucose median (iqr) mmol/l 3.9 (3.4–4.4)
Blood pressure median (iqr) mmHg
diastolic 70 (65–80)
systolic 120 (110–135)
Hypertension 24.2 %
Myocardial infarctiona 1.2 %
Individuals with infectious diseasesb
Malaria species 77.7 %
Protozoa 100.0 %
Helminths 21.5 %
Proinflammatory markersc
Interleukin-6 median (iqr) ng/l 1.9 (1.4–2.7)
C-reactive protein median (iqr) mg/l 1.0 (0.4–2.7)
Lifetime fertility is expressed as the total number of children born per woman.
Hypertension is defined as a systolic blood pressure of 140 mmHg or higher
and/or a diastolic blood pressure of 90 mmHg or higher. Myocardial infarction
represents electrocardiographically detected definite myocardial infarction.
Circulating C-reactive protein (CRP) and interleukin-6 (IL6) have been measured in
venous plasma samples. Iqr: interquartile range.
aDetermined in a subpopulation of 610 individuals.
bDetermined in 261 individuals for whom blood and stool samples
were available.
cDetermined in 266 individuals for whom plasma samples were available.
Table 2 Characteristics of the three cases with atrial
fibrillation in the Ghanaian study population
Case Sex Age HR RR BMI Gluc Smok Isch Infa SES
1 ♀ 76 104 140/85 21.8 3.2 – – – 420
2 ♂ 76 80 165/80 17.5 3.1 – – – 530
3 ♂ 76 104 125/80 19.1 3.8 + – – 1,030
HR: ventricular heart rate (/min). RR: systolic/diastolic blood pressure (mmHg).
BMI: body mass index (kg/m2). Smok: smoking. Gluc: capillary blood glucose
concentration (mmol/l). Isch: electrocardiographic myocardial ischaemia-like
repolarisation abnormalities. Infa: electrocardiographic infarction. SES: household
value (US$). Smok, Isch, and Infa, are designated as present (+) or absent (–).
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To compare our results with a western population, we
derived data on the prevalences of the risk factors of
atrial fibrillation from studies performed in the general
population of the USA. Age and ethnicity-specific distri-
butions of BMI and CRP and the prevalence of hyper-
tension were derived from the National Health and
Nutrition Examination Survey (NHANES) performed in
1999-2000 [24]. For the USA, the definition of hyperten-
sion was extended to include individuals using antihy-
pertensive medication. Distributions of IL6 for white and
black Americans of 65 years of age or older were derived
from a publication by Cohen and colleagues [25].
These reference sources classified American ethnicities
as white or black. Although they seem synonymous with
Caucasian and African American ethnicities, we adopted
their terminology for compatibility.
Analyses
Prevalences of atrial fibrillation were calculated as the
number of cases divided by the total number of inhabi-
tants per ten-year age group and given as percentages.
Prevalences of risk factors were given as percentages.
Distributions of continuous variables were described by
medians. Confidence intervals were calculated using
Wilson’s formula for prevalences and using the binomial
distribution for medians. Statistical analyses were per-
formed with IBM SPSS Statistics version 20.
Results
Table 1 provides a description of the demographic charac-
teristics, the established risk factors of atrial fibrillation,
and infectious and inflammatory markers for the Ghan-
aian study population aged 50 years and older. In the
study population, the prevalences and levels of the estab-
lished risk factors, including obesity, dysglycaemia, hyper-
tension, and myocardial infarction, were very low. The
levels of the inflammatory markers interleukin-6 (IL6) and
C-reactive protein (CRP) are described. Infectious diseases
were highly prevalent. These characteristics were similar
between the entire registered population, the study popu-
lation selected for the electrocardiographic and clinical
investigations, and the subpopulation in which the bio-
chemical investigations were performed, except for minor
differences in the distributions of age and sex. The similar-
ities remained after stratification by sex.
Electrocardiograms were obtained from 921 partici-
pants, of whom 479 males (52.0%). The median (inter-
quartile) heart rate was 71 (63–80) per minute. Sinus
bradycardia and tachycardia were present in 159 (17.3%)
and 32 (3.5%) individuals. Three individuals had atrial
fibrillation, equalling 0.3% (95% CI: 0.1–1.0%).
Table 2 shows characteristics of the three cases with
atrial fibrillation in the Ghanaian study population. Of
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two were affected by hypertension. The third case was a
smoker. Only for the latter case inflammatory markers
were known; compared with the entire study population
as well as the USA, these levels were low for both IL6
and CRP.
Figure 1 compares the distributions over age of the
most important established risk factors of atrial fibrilla-
tion and compares the levels of the inflammatory
markers with known distributions and levels in the USA,
separated for white and black ethnicities. The levels of
BMI and hypertension in the Ghanaian study popula-
tion were lower than those of both white and black
Americans. The levels of IL6 were comparable with, but
the levels of CRP were lower than those of both white and
black Americans.
Discussion
In this study we showed that atrial fibrillation was very
scarce after the age of 50 years in a traditional rural
community in Africa. The near absence of atrial fibrilla-
tion in the Ghanaian study population confirms the low
prevalences that have been found by a few studies inFigure 1 Risk factors of atrial fibrillation in the Ghanaian study popul
body mass index (BMI) is given as median levels over age and prevalences
defined as a systolic blood pressure of 140 mmHg or higher and/or a diast
with antihypertensive medication. As proinflammatory markers, distribution
levels over the age of 65 and 50 years, respectively. For the Ghanaian study
prevalences are given for white and black ethnicities in the general popula
1999-2000 [24] and from Cohen and colleagues [25].other traditional African populations. In rural Tanzanians
aged 70 years and older, its prevalence was 0.7% [11]. In
the South African Bantu population, atrial fibrillation was
detected in 0.2% of patients attending a cardiac clinic but
not diagnosed with cardiac disease [26]. In patients from
the Bantu population hospitalised because of cardiac fail-
ure, it was present in 12% [27].
The prevalence of atrial fibrillation in urban African
populations is higher than those in rural African popula-
tions. In a South-African study covering both urban and
rural communities, atrial fibrillation was detected in 2%
of blacks over the age of 30 years [28]. In two large car-
diologic hospitals, 4.6% and 5.5% of the admitted pa-
tients had atrial fibrillation at relatively young ages
[29,30]. Among cardiologic hospitals across several Sub-
Saharan African countries, atrial fibrillation was found
in 18% of cases with acute heart failure [31].
The prevalence of atrial fibrillation in western popula-
tions is higher than those in rural African populations.
Several studies in patient populations and the general
populations of the USA and Western Europe have re-
ported its prevalence to rise from less than 2% around
the age of 50 years up to 10 to 20% after the age ofation and the USA. As established risk factors, the distribution of
of hypertension are given as percentages over age. Hypertension is
olic blood pressure of 90 mmHg or higher, and, for the USA, treatment
s of interleukin-6 (IL6) and C-reactive protein (CRP) are given as median
population, 95% confidence intervals are given. As references,
tion of the USA. These data have been derived from NHANES
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lar increases over age have been described for both white
and black Americans [2].
The low prevalence of atrial fibrillation in rural African
populations compared with urban African and western
populations can be explained by a similarly lower preva-
lence of its established risk factors, including obesity, dia-
betes, hypertension, and cardiovascular disease. These risk
factors are closely related to a sedentary lifestyle [5,10].
With the transition, urbanisation, and ageing of African
populations, a sedentary lifestyle is adopted and the preva-
lence of atrial fibrillation rises [12,30].
Interestingly, cases of atrial fibrillation described in
African populations are accompanied by underlying car-
diac disorders in proportions up to 90%, which contrasts
with the large proportion of idiopathic cases described
in western populations [3,4]. Mostly, these cardiac disor-
ders concern hypertensive cardiopathy and rheumatic
valvular heart disease [12,27,29,30]. In the Ghanaian
study population, two of the three cases suffered from
hypertension. This relationship between cardiac disease
and atrial fibrillation supports that atrial fibrillation may
be mainly propagated by obesity, diabetes, hypertension,
and cardiovascular disease.
Recently, inflammation has been postulated to play an
important role in the pathogenesis of atrial fibrillation
[7]. In the Ghanaian study population the level of IL6,
an instigator of a proinflammatory response, was similar
to that in the general population of the USA. Earlier we
have shown that the study population is biochemically
and genetically enriched with proinflammatory markers,
probably due to the endemic high infectious load
[23,32,33]. On the other hand, the level of CRP, a marker
of systemic inflammation, was lower compared with the
USA. Similarly, we have previously reported that the
median level of CRP as well as the prevalence of mildly
elevated levels of CRP was lower in the study population
compared with the general population in the Netherlands.
This difference was attributable to a lower BMI in the
Ghanaian study population [34]. Together, these findings
may indicate that, while the capacity to generate an in-
flammatory response is preserved, systemic inflammation
is uncommon in the Ghanaian study population.
Mendelian randomisation has shown that an elevation
of CRP is rather an effect than a cause of atrial fibrilla-
tion [35]. This interpretation is supported by observa-
tions that deny an association between CRP level and
history of atrial fibrillation, but confirm that CRP is
elevated during episodes of atrial fibrillation or due to
coexistence of hypertension or obesity [36-38]. Inflam-
matory processes related to atrial fibrillation seem to be
caused by ischaemic or oxidative injury of atrial myo-
cytes, which is again caused by obesity, diabetes, hyper-
tension, and cardiac disease [39,40]. In the Ghanaianstudy population, hypertension is present in only about
a quarter and obesity, dysglycaemia, and cardiovascular
disease are rare. The low levels of CRP match with the
close relation between these risk factors and inflamma-
tion. We have observed a similar pattern when studying
inflammation in relation to peripheral and coronary ar-
terial disease in this study population [21].
While we found almost no atrial fibrillation in the
Ghanaian study population, hypertension was present in
a considerable proportion. Similarly, in western popula-
tions, black ethnicities are more affected by obesity, dia-
betes, and hypertension, but less often develop atrial
fibrillation compared with white ethnicities [5,8,11].
Meanwhile, the associations between these risk factors
and atrial fibrillation are similar in both ethnicities
[5,9,41,42]. A solution of this paradox may be provided
by the higher sensitivity that seems required for methods
to detect atrial fibrillation in blacks compared with
whites [43]. However, more research in different popula-
tions is needed to unravel the interactions between en-
vironmental and genetic risk factors [13].
The low prevalence of atrial fibrillation in the Ghanaian
study population may also be a result of a lack of risk
factors other than those measured in this study. No
data was available on the prevalence of rheumatic heart
disease, which is a common cause of atrial fibrillation
in African populations [12,29,30]. Furthermore, we had
no information on thyroid disease, smoking, and alco-
hol use, which are risk factors of atrial fibrillation in
western populations [3,4].
Differences between ethnicities in the risks of atrial
fibrillation are possibly caused by genetic factors. Mul-
tiple genetic polymorphisms have been associated with
an elevated risk of atrial fibrillation, mainly in studies on
populations from European decent. Yet, the effects of
these associations are modest and differ between ethnici-
ties [44,45]. The lower prevalence of atrial fibrillation
among black Americans compared with white Americans
may be a result of a lower frequency of genetic var-
iants that predispose to atrial fibrillation among blacks.
As black Americans show great genetic similarity with
populations in West Africa, where the Ghanaian study
population is located [46], a lower frequency of such
genetic variants may likewise explain why atrial fibrilla-
tion was scarce in the Ghanaian study population. How-
ever, this remains speculative: one report states that
European genetic admixture does not explain the differ-
ences in prevalence of atrial fibrillation between white
and black Americans [47], while another report contra-
dicts this [48]. Moreover, if the frequency of genetic
variants that predispose to atrial fibrillation would be
lower among black Americans, the greater prevalence
of atrial fibrillation among black Americans compared
with the Ghanaian study population reinforces the essential
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variants.
The scarcity of atrial fibrillation in our study popula-
tion can also be explained by selective survival of un-
affected individuals. When sufficient medical care is
absent, patients with atrial fibrillation may decease early
from the underlying disorders or complications, such as
cardiac disease or stroke. A study on patients with atrial
fibrillation in rural Tanzania reports that 8 out of 15
died within a year after detection [11]. In a larger group
in Cameroon one-year mortality was 30%, of which
more than half was of cardiovascular origin. Of the sur-
vivors, 18% experienced cerebrovascular accidents [12].
On the other hand, with relatively low risk scores
[12,30] atrial fibrillation in these populations seems un-
likely to be so severely lethal to render infinitesimal
prevalence estimates. In line with this, we have deter-
mined in another study [49], by means of verbal autopsy
on 1,263 of the 1,406 deaths that were registered in our
cohort population, that only 2.7% died from cardiovas-
cular causes. For those who died at the age of 50 years
or older, this was 4.5%.
This study on atrial fibrillation in a traditional rural
African population has limitations. First, the use of two
subsequent electrocardiographic recordings of ten sec-
onds may be insufficient to detect all cases of atrial fib-
rillation. More elaborate screening techniques used in
western populations yield more reliable estimates of its
prevalence; this difference in methodology hampers the
comparison of our results with data from western popu-
lations. Second, the documentation of the cardiovascular
risk factors lacks information on history and family history
of cardiovascular disease. Third, due to different life ex-
pectancies, the number of elderly aged 50 years and older
is lower in our population than in western populations.
Fourth, due to the cross-sectional nature of this study,
presence or absence of causality in the relationships be-
tween the established risk factors, systemic inflammation,
and atrial fibrillation cannot be demonstrated.
The data on atrial fibrillation and its risk factors in the
Ghanaian study population are not necessarily generalis-
able to other African populations, as they vary genetically
and culturally [46]. In the same manner, the comparison
between the Ghanaian study population and the general
population of the USA may not reflect a universal differ-
ence between African and western populations. Compari-
sons between divergent populations are informative, but
also complicated. As described above, some possible dif-
ferences between the Ghanaian study population and the
general population of the USA remain largely unknown.
More research in different non-western populations is
needed to overcome the limitations of this study and to
extend the scarce knowledge on atrial fibrillation in such
populations [13].Conclusion
In conclusion, we have shown that atrial fibrillation is
nearly absent in a traditional rural community in Ghana.
The low prevalence compared with western societies can
be explained by the rareness of its established risk fac-
tors, including obesity, diabetes, hypertension, and car-
diac disease, as well as systemic inflammation, which are
closely related to a sedentary lifestyle and uncommon in
this population. Future research is needed to elucidate
the roles of other risk factors and genetic factors.
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